TherapeuticsMD
TXMD
#10731
Rank
โ‚น1.83 B
Marketcap
โ‚น158.47
Share price
-5.52%
Change (1 day)
-0.63%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2026 (TTM): โ‚น7.06

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is โ‚น7.41. In 2021 the company made an earnings per share (EPS) of -โ‚น2,011 an increase over its 2020 EPS that were of -โ‚น3,104.

EPS history for TherapeuticsMD from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น7.06
2021-โ‚น2,011-35.22%
2020-โ‚น3,104-5.63%
2019-โ‚น3,29020.34%
2018-โ‚น2,73455.26%
2017-โ‚น1,761-19.15%
2016-โ‚น2,178-6%
2015-โ‚น2,31742.86%
2014-โ‚น1,62252.17%
2013-โ‚น1,066

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น65.80 787.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น542.27 7,214.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-โ‚น358.63-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น141.71 1,811.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-โ‚น2,343-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA